Ribomic Inc. announced non-consolidated earnings results for the first quarter ended June 30, 2017. For the quarter the company reported operating revenues of ¥17.900 million against ¥24.999 million a year ago. Operating loss was ¥158.493 million against ¥148.687 million a year ago. Ordinary loss was ¥162.972 million against ¥147.856 million a year ago. Loss for the period was ¥163.504 million or ¥12.29 per share against ¥148.158 million or ¥11.23 per share a year ago. Loss before income taxes was ¥163.201 million against ¥147.856 million a year ago.

For the year ending March 31, 2018, on non-consolidated basis, the company expects to report operating revenues of ¥65 million, operating loss of ¥1,002 million, ordinary loss of ¥873 million and loss of ¥875 million or ¥65.86 per share.